Engineering HSV-1 for oncolytic therapy: From molecular entry mechanisms to retargeting strategies

Oncolytic viruses (OVs) represent a cutting-edge approach to cancer immunotherapy, characterized by their ability to selectively infect and eliminate tumor cells while sparing healthy tissues. Among the diverse OVs, type 1 herpes simplex virus (HSV-1) stands out due to its robust oncolytic activity,...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Yufang Zou, Juan Tao, Yingzheng Gao, Jixuan Wang, Pengfei Wang, Jingyuan Yan, Zuqing Nie, Dewei Jiang, Xinwei Huang
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	KeAi Communications Co., Ltd. 2026-03-01
Saila:	Genes and Diseases
Gaiak:	Cell fusion Glycoprotein genetic engineering Herpes simplex virus type I Oncolytic virotherapy Systemic administration Tropism-retargeting
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2352304225002867
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!